{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:03:52Z","timestamp":1790946232923,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jcyt.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T07:06:23Z","timestamp":1752822383000},"page":"1338-1343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Donor T-cell and myeloid chimerism is higher after cord blood transplant than with other cell sources"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8642-2230","authenticated-orcid":false,"given":"Rubiya","family":"Nadaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omima","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0363-163X","authenticated-orcid":false,"given":"Oana","family":"Mirci-Danicar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Hanasoge-Nataraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividhya","family":"Senthil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6865-8509","authenticated-orcid":false,"given":"Claire","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-8107","authenticated-orcid":false,"given":"Kay","family":"Poulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jcyt.2025.07.003_bib0001","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.5966\/sctm.2014-0151","article-title":"Concise review: umbilical cord blood transplantation: past, present, and future","volume":"3","author":"Mu\u00f1oz","year":"2014","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"10.1016\/j.jcyt.2025.07.003_bib0002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3324\/haematol.2009.005694","article-title":"Cord blood transplantation: state of the art","volume":"94","author":"Gluckman","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2025.07.003_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1232281","article-title":"Immunology of cord blood T-cells favors augmented disease response during clinical pediatric stem cell transplantation for acute leukemia","volume":"11","author":"Borrill","year":"2023","journal-title":"Front Pediatr"},{"issue":"12","key":"10.1016\/j.jcyt.2025.07.003_bib0004","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/bmt.2016.186","article-title":"Chronic graft-versus-host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation","volume":"51","author":"Gutman","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2025.07.003_bib0005","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3389\/fimmu.2019.02769","article-title":"The evolution of T cell depleted haploidentical transplantation","volume":"10","author":"Ruggeri","year":"2019","journal-title":"Front Immunol"},{"issue":"17","key":"10.1016\/j.jcyt.2025.07.003_bib0006","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood-2014-04-571570","article-title":"T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT","volume":"124","author":"Luo","year":"2014","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2025.07.003_bib0007","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1182\/blood-2023-186293","article-title":"Mismatched unrelated donor transplantation with PTCy-based GVHD prophylaxis is associated with better survival than double unit umbilical cord blood transplantation in patients with AML in first CR: a study from the ALWP of the EBMT","volume":"142","author":"Baron","year":"2023","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jcyt.2025.07.003_bib0008","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3324\/haematol.2014.109280","article-title":"Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen","volume":"99","author":"Ruggeri","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jcyt.2025.07.003_bib0009","first-page":"705","article-title":"Umbilical cord blood transplantation: still growing and improving","volume":"10","author":"Broxmeyer","year":"2021","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"10.1016\/j.jcyt.2025.07.003_bib0010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor hematopoietic stem-cell transplantation in adults with acute leukemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"issue":"17","key":"10.1016\/j.jcyt.2025.07.003_bib0011","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1182\/bloodadvances.2020001737","article-title":"Cord blood CD8+ T-cell expansion following granulocyte transfusions eradicates refractory leukemia","volume":"4","author":"Hiwarkar","year":"2020","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jcyt.2025.07.003_bib0012","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1182\/bloodadvances.2022009253","article-title":"T-replete cord transplants give superior outcomes in high-risk and relapsed\/refractory pediatric myeloid malignancy","volume":"7","author":"Horgan","year":"2023","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.jcyt.2025.07.003_bib0013","first-page":"1005","article-title":"HLA-DRB1 mismatch is associated with decreased relapse in adult patients with acute myeloid leukemia undergoing single-unit myeloablative umbilical cord blood transplantation","volume":"50","author":"Konuma","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2025.07.003_bib0014","first-page":"1129","article-title":"Impact of intensified myeloablative conditioning on unrelated cord blood transplantation for acute myeloid leukemia: a nationwide retrospective study","volume":"52","author":"Kanda","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2025.07.003_bib0015","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcyt.2025.07.003_bib0016","first-page":"42","article-title":"Hematopoietic stem cell transplantation in inborn errors of metabolism","volume":"47","author":"Boelens","year":"2010","journal-title":"Semin Hematol"},{"issue":"13","key":"10.1016\/j.jcyt.2025.07.003_bib0017","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jcyt.2025.07.003_bib0018","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.jcyt.2025.07.003_bib0019","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1182\/blood.V114.22.4475.4475","article-title":"Myeloid chimerism reflects engraftment of donor hematopoiesis, whereas T cell chimerism reflects survival and expansion of donor and recipient residual mature T cells early after T cell depleted allogeneic stem cell transplantation","volume":"114","author":"Harskamp","year":"2009","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.jcyt.2025.07.003_bib0020","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3390\/cells13242119","article-title":"Mixed T-cell chimerism following hematopoietic cell transplantation for non-malignant disorders is common, facilitates anti-viral immunity, and is not associated with graft failure in pediatric patients","volume":"13","author":"Nadaf","year":"2024","journal-title":"Cells"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2025.07.003_bib0021","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/blood-2021-148144","article-title":"Chimerism of blood T-cells and leukemia lineage cells following myeloablative hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease","volume":"138","author":"Khanolkar","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jcyt.2025.07.003_bib0022","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2025.07.003_bib0023","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbmt.2014.12.029","article-title":"Chimerism-based pre-emptive immunotherapy with fast withdrawal of immunosuppression and donor lymphocyte infusions after allogeneic stem cell transplantation for pediatric hematologic malignancies","volume":"21","author":"Horn","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jcyt.2025.07.003_bib0024","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/JCMA.0000000000000992","article-title":"Donor lymphocyte infusion for prophylaxis and treatment of relapse in pediatric hematologic malignancies after allogeneic hematopoietic stem cell transplant","volume":"86","author":"Hou","year":"2023","journal-title":"J Chin Med Assoc"},{"issue":"1","key":"10.1016\/j.jcyt.2025.07.003_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41409-018-0203-8","article-title":"Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia","volume":"54","author":"Craddock","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jcyt.2025.07.003_bib0026","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/bbmt.2001.v7.pm11669214","article-title":"Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop","volume":"7","author":"Antin","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2025.07.003_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1704525","article-title":"Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme","volume":"34","author":"Khan","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jcyt.2025.07.003_bib0028","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2025.07.003_bib0029","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1182\/blood-2006-04-020172","volume":"109","author":"Takahashi","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jcyt.2025.07.003_bib0030","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1172\/JCI129965","article-title":"Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease","volume":"130","author":"Divito","year":"2020","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.jcyt.2025.07.003_bib0031","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0301-472X(03)00160-7","article-title":"Coexistent na\u00efve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood","volume":"31","author":"Szabolcs","year":"2003","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.jcyt.2025.07.003_bib0032","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/cimm.1994.1053","article-title":"Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation","volume":"154","author":"Risdon","year":"1994","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.jcyt.2025.07.003_bib0033","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1365-2249.1999.00920.x","article-title":"Rapid conversion of naive to effector T cell function counteracts diminished primary human newborn T cell responses","volume":"116","author":"Early","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2025.07.003_bib0034","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fimmu.2019.00573","article-title":"New paradigm in the role of regulatory T cells during pregnancy","volume":"10","author":"Tsuda","year":"2019","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2025.07.003_bib0035","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2141.2011.08994.x","article-title":"Omission of in vivo T-cell depletion promotes rapid expansion of na\u00efve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant","volume":"156","author":"Chiesa","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2025.07.003_bib0036","doi-asserted-by":"crossref","first-page":"570550","DOI":"10.3389\/fimmu.2020.570550","article-title":"Maturation and phenotypic heterogeneity of human CD4+ regulatory T cells from birth to adulthood and after allogeneic stem cell transplantation","volume":"11","author":"Matos","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2025.07.003_bib0037","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2172-8-18","article-title":"Cytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factors","volume":"8","author":"Nitsche","year":"2007","journal-title":"BMC Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2025.07.003_bib0038","first-page":"732","article-title":"Complete donor T-cell chimerism is associated with a lower incidence of relapse compared to mixed chimerism","volume":"20","author":"Khanal","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2025.07.003_bib0039","first-page":"249","article-title":"Low donor chimerism early after reduced-intensity conditioning HSCT is an independent risk factor for relapse and impaired survival","volume":"126","author":"Koreth","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2025.07.003_bib0040","article-title":"Serial chimerism analysis detects decreasing donor chimerism as a predictor of leukemia relapse","volume":"3","author":"Thiede","year":"2013","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.jcyt.2025.07.003_bib0041","first-page":"314","article-title":"Day 30 whole blood and T-cell mixed donor chimerism predict relapse risk in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation","volume":"30","author":"Khanal","year":"2024","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2025.07.003_bib0042","first-page":"e198","article-title":"The role of donor chimerism in hematopoietic stem cell transplantation for non-malignant disorders","volume":"26","author":"Zimmerman","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jcyt.2025.07.003_bib0043","first-page":"797","article-title":"Chimerism status and outcomes in patients with non-malignant diseases undergoing HSCT: a retrospective study","volume":"44","author":"Ozyurek","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2025.07.003_bib0044","first-page":"1537","article-title":"Comparison of full donor chimerism and stable mixed chimerism in patients with non-malignant diseases post-HSCT","volume":"19","author":"Bader","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jcyt.2025.07.003_bib0045","first-page":"1873","article-title":"Chimerism dynamics in children with non-malignant diseases after allogeneic HSCT: implications for graft stability and intervention","volume":"23","author":"Buchbinder","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2025.07.003_bib0046","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/bjh.18863","article-title":"Granulocyte transfusion during cord blood transplant for relapsed, refractory AML is associated with massive CD8+ T-cell expansion, significant cytokine release syndrome and induction of disease remission","volume":"202","author":"Borrill","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2025.07.003_bib0047","doi-asserted-by":"crossref","unstructured":"Milano F, D\u2019Angelo A, Chen Y, Patel S, Nguyen T, Forman SJ. Dilanubicel, a non-HLA-matched pooled universal product, transforming single cord blood transplantation success rates. Blood. 2024;144(Suppl 1):377.","DOI":"10.1182\/blood-2024-206088"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2025.07.003_bib0048","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1182\/blood-2023-187446","article-title":"Infusion of UM171-expanded cord blood led to excellent survival in patients with high-risk leukemias: results from two independent phase II studies","volume":"142","author":"Milano","year":"2023","journal-title":"Blood"},{"issue":"6203","key":"10.1016\/j.jcyt.2025.07.003_bib0049","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1256337","article-title":"UM171 expands human hematopoietic stem cells and optimizes their transplantation potential","volume":"345","author":"Fares","year":"2014","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jcyt.2025.07.003_bib0050","article-title":"UM171 expansion of cord blood improves donor availability and HLA matching for allogeneic transplantation: a phase I-II study","volume":"7","author":"Cohen","year":"2020","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.jcyt.2025.07.003_bib0051","first-page":"e380","article-title":"Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1\u20132 safety and feasibility study","volume":"9","author":"Cohen","year":"2022","journal-title":"Lancet Haematol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925007868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925007868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:10:16Z","timestamp":1762546216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324925007868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1465324925007868"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.07.003","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor T-cell and myeloid chimerism is higher after cord blood transplant than with other cell sources","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}